https://dementias.today/story/birmingham-study-identifies-brain-receptor-as-possible-alzheimer-s-inflammation--uousm Dementias Today en 2026-10-10T00:28:31.315Z Birmingham study identifies brain receptor as possible Alzheimer's inflammation target https://dementias.today/story/aviadobio-reports-dose-linked-rise-in-brain-protein-among-ftd-gene-therapy-patie-4x2ki Dementias Today en 2026-10-09T09:25:25.475Z AviadoBio Reports Dose-Linked Rise in Brain Protein Among FTD Gene Therapy Patients https://dementias.today/story/usc-modeling-finds-starting-donanemab-two-years-earlier-raises-its-lifetime-valu-fpspf Dementias Today en 2026-10-09T01:25:31.262Z USC Modeling Finds Starting Donanemab Two Years Earlier Raises Its Lifetime Value by a Third https://dementias.today/story/plasma-proteomics-study-finds-lecanemab-triggers-distinct-biological-response-pa-abslk Dementias Today en 2026-10-08T21:25:11.851Z Plasma Proteomics Study Finds Lecanemab Triggers Distinct Biological Response Patterns, Not One Effect https://dementias.today/story/uc-davis-opens-trial-of-ai-linked-pill-dispenser-for-people-with-memory-loss-lw5qt Dementias Today en 2026-10-08T07:30:10.931Z UC Davis opens trial of AI-linked pill dispenser for people with memory loss https://dementias.today/story/arvinas-reports-phase-1-eye-movement-and-biomarker-data-for-parkinson-s-lrrk2-de-8tph0 Dementias Today en 2026-10-08T07:30:10.288Z Arvinas Reports Phase 1 Eye-Movement and Biomarker Data for Parkinson's LRRK2 Degrader ARV-102